Merck Sharp & Dohme Sweden AB

Company

Investment-firm

Last deal

$586K

Amount

Post-IPO Equity

Stage

25.11.2018

Date

2

all rounds

$5.6M

Total amount

General

About Company
Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Merck, Schering Plough

founded date

01.01.1891

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Founded in 1891 and headquartered in Kenilworth, NJ, Merck is a leading research-intensive biopharmaceutical company. Their portfolio includes vaccines, medications, and consumer and animal health products that have the potential to benefit millions of people worldwide. With a mission to discover and develop innovative solutions for various diseases, Merck aims to be at the forefront of the biopharmaceutical industry.
Contacts

Social url